Gastrointestinal cancer: Which way is forward in the treatment of rectal cancer?

R.L. Jansen; G.L. Beets

doi:10.1038/nrclinonc.2012.217

Gastrointestinal cancer: Which way is forward in the treatment of rectal cancer?

R.L. Jansen, G.L. Beets^*

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Preoperative 5-fluorouracil-based chemoradiation with optimal surgery provides very effective local control in locally advanced rectal cancer. Does adding oxaliplatin as a radiosensitizer provide any additional benefit? Is more always better? Jansen, R. L. H. & Beets, G. L. Nat. Rev. Clin. Oncol. 10, 12-13 (2013); published online 11 December 2012; doi:10.1038/nrclinonc.2012.217

Original language	English
Pages (from-to)	12-13
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/nrclinonc.2012.217
Publication status	Published - 1 Jan 2013

Keywords

PHASE-III TRIAL
CHEMORADIATION
CHEMORADIOTHERAPY
OXALIPLATIN

Access to Document

10.1038/nrclinonc.2012.217

Cite this

@article{c1c7ee76b19942589dd64c1a519da6fa,

title = "Gastrointestinal cancer: Which way is forward in the treatment of rectal cancer?",

abstract = "Preoperative 5-fluorouracil-based chemoradiation with optimal surgery provides very effective local control in locally advanced rectal cancer. Does adding oxaliplatin as a radiosensitizer provide any additional benefit? Is more always better? Jansen, R. L. H. & Beets, G. L. Nat. Rev. Clin. Oncol. 10, 12-13 (2013); published online 11 December 2012; doi:10.1038/nrclinonc.2012.217",

keywords = "PHASE-III TRIAL, CHEMORADIATION, CHEMORADIOTHERAPY, OXALIPLATIN",

author = "R.L. Jansen and G.L. Beets",

year = "2013",

month = jan,

day = "1",

doi = "10.1038/nrclinonc.2012.217",

language = "English",

volume = "10",

pages = "12--13",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",